Dm. Kovacs et al., Staurosporine-induced activation of caspase-3 is potentiated by presenilin1 familial Alzheimer's disease mutations in human neuroglioma cells, J NEUROCHEM, 73(6), 1999, pp. 2278-2285
Familial Alzheimer's disease (FAD) mutant forms of presenilin I (PS1) and 2
have been shown to sensitize cells to apoptotic cell death. Here we explor
e the effects of FAD mutant forms of PS1 on caspase activation during apopt
osis, We show that caspase activation leads to increased generation of alte
rnative C-terminal fragments (CTFs) from mutant as compared to wild-type (w
t) PS1. For this purpose, very low expression levels of wt, A246E, L286V, a
nd Delta E10 FAD mutant PS1 proteins in stably transfected human H4 neurogl
ioma cells were used to avoid artifactual induction of spontaneous apoptosi
s due to overexpression of PS1, Staurosporine treatment of these cells resu
lted in increased cell death and up to a 10-fold increase in caspase-3 acti
vation in mutant versus wt PS1-expressing cell lines. Correspondingly, rela
tive levels of caspase-cleaved PS1 CTFs were increased by five- to sixfold
in the FAD mutant versus wt PS1 cells. Elevated caspase activation and casp
ase cleavage of FAD mutant PS1 suggest the possibility of either a direct p
roapoptotic effect of mutant PS1 or interference of mutant PS1 with antiapo
ptotic effects of wt PS1.